Advertisement

Topics

Agilent Technologies Extends Biopharma Portfolio with Advanced Mass Spec System

11:00 EST 7 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
New LC/Q-TOF MS System with AdvanceBio Peptide Plus Column Provide Optimization for Biopharma Research Agilent Technologies Inc. (NYSE: A) introduces the latest addition to its portfolio of solutions for biopharmac...

Other Sources for this Article

Agilent Technologies
Victoria Wadsworth-Hansen, +1-408-553-2005
+45 29 33 69 80
victoria.wadsworth-hansen@agilent.com

NEXT ARTICLE

More From BioPortfolio on "Agilent Technologies Extends Biopharma Portfolio with Advanced Mass Spec System"

Advertisement
Quick Search
Advertisement
Advertisement